EP0301861A1 — Cell proliferation inhibitors
Assigned to Takeda Pharmaceutical Co Ltd · Expires 1989-02-01 · 37y expired
What this patent protects
A compound of the formula: wherein, R¹ and R² are the same or different, representing methyl or methoxy groups, or form -CH=CH-CH=CH- by binding to each other; R³ is an aromatic group or a heterocyclic group which may be substituted; and n is an integer of 2 to 8, shows inh…
USPTO Abstract
A compound of the formula: wherein, R¹ and R² are the same or different, representing methyl or methoxy groups, or form -CH=CH-CH=CH- by binding to each other; R³ is an aromatic group or a heterocyclic group which may be substituted; and n is an integer of 2 to 8, shows inhibitory effect of cell proliferation and is useful as cell proliferation inhibitor.
Drugs covered by this patent
- Beleodaq (belinostat) · Acrotech Biopharma
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.